I am currently a Postdoctoral Research Fellow at the University of Pavia (Italy), working in the Laboratory of Cell Biology and Neurobiology. I obtained my PhD in Genetics, Molecular, and Cellular Biology in 2024 at the same institution, with a translational research project focused on glioblastoma biology and the development of innovative therapeutic strategies for brain tumors. During my training, I spent time as a visiting researcher at Harvard Medical School / Brigham and Women’s Hospital (Boston, USA), within the Harvey Cushing Neurooncology Research Laboratories, where I worked on advanced 3D glioblastoma models and blood–brain barrier systems.
My background is in neuro-oncology, cancer cell biology, and translational biotechnology, with hands-on experience in 2D and 3D tumor models, organoids, BBB platforms, and in vivo preclinical models. In my research, I have contributed to the evaluation of novel platinum-based metallodrugs for glioblastoma, with particular interest in their ability to cross the blood–brain barrier, reduce neurotoxicity, and modulate immune responses in preclinical settings. I am also interested in tumor–microenvironment interactions and brain tumor immunology.
I am currently a Postdoctoral Research Fellow at the University of Pavia (Italy), working in the Laboratory of Cell Biology and Neurobiology. I obtained my PhD in Genetics, Molecular, and Cellular Biology in 2024 at the same institution, with a translational research project focused on glioblastoma biology and the development of innovative therapeutic strategies for brain tumors. During my training, I spent time as a visiting researcher at Harvard Medical School / Brigham and Women’s Hospital (Boston, USA), within the Harvey Cushing Neurooncology Research Laboratories, where I worked on advanced 3D glioblastoma models and blood–brain barrier systems.
My background is in neuro-oncology, cancer cell biology, and translational biotechnology, with hands-on experience in 2D and 3D tumor models, organoids, BBB platforms, and in vivo preclinical models. In my research, I have contributed to the evaluation of novel platinum-based metallodrugs for glioblastoma, with particular interest in their ability to cross the blood–brain barrier, reduce neurotoxicity, and modulate immune responses in preclinical settings. I am also interested in tumor–microenvironment interactions and brain tumor immunology.